China NMPA Drug Inspection - Guizhou Shouxian Pharmaceutical Co., Ltd. - glucose injection
China NMPA drug inspection for Guizhou Shouxian Pharmaceutical Co., Ltd. published January 09, 2018. Drug: glucose injection. The Xinjiang Uygur Autonomous Region Food and Drug Administration (Xinjiang FDA) issued an announcement on January 9, 20
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Guizhou Shouxian Pharmaceutical Co., Ltd. published January 09, 2018. Drug: glucose injection. The Xinjiang Uygur Autonomous Region Food and Drug Administration (Xinjiang FDA) issued an announcement on January 9, 20
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox